Results 171 to 180 of about 156,550 (306)

Intersectionality-Informed HIV Cure-Related Research at the End of Life: A Call to Action. [PDF]

open access: yesInt J Environ Res Public Health
Ahmed A   +19 more
europepmc   +1 more source

Consumer Behavior Toward Health‐Related Mobile Applications: A Hybrid Review and Future Agenda

open access: yesJournal of Consumer Behaviour, EarlyView.
ABSTRACT Mobile health (MH) has the potential to address many consumer challenges, but consumer responses to it remain varied. In this regard, the consumer's perspective on MH is becoming increasingly attractive to academia and business. This review aims to synthesize and analyze 103 studies from 2010 to 2024 using the Scientific Procedures and ...
Omer Faruk Celebi   +3 more
wiley   +1 more source

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection

open access: yesJournal of Virus Eradication, 2019
C. Gay   +16 more
doaj   +1 more source

The CanCURE Survey: Gender-Based Differences in HIV Cure Research Priorities. [PDF]

open access: yesJ Pers Med
Lu J   +11 more
europepmc   +1 more source

Shedding Light on Synthetic Autocatalysis: From Conventional Closed‐Shell Chemistries to Overlooked Open‐Shell Occurrences

open access: yesChemistry – A European Journal, EarlyView.
Why add another catalyst when the product itself holds the power to catalyze its own formation? Autocatalysis in synthetic chemistry enhances reaction efficiency and uncovers novel catalytic behavior across both closed‐shell and open‐shell systems, expanding reactivity and enabling innovative design strategies.
Jaspreet Kaur, Joshua P. Barham
wiley   +1 more source

In vitro demonstration of a potential role for STING agonist in HIV cure

open access: yesJournal of Virus Eradication, 2019
A. Koblansky   +8 more
doaj   +1 more source

Consensus Building on Strategies That Address Medical Mistrust to Better Engage Priority Populations in HIV Cure Research. [PDF]

open access: yesBehav Med
Korolkova A   +6 more
europepmc   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy